全体要約
細胞治療再生医療は、幹細胞やその誘導体を用いて、病気や機能不全、損傷した組織の修復を促進する技術です。2022年の世界の細胞治療再生医療市場は、地域や市場セクターごとに分析され、2023年から2029年の予測が示されています。アメリカ、中国、ヨーロッパの市場はそれぞれ成長が見込まれています。
この市場には、NK細胞治療やCAR-T細胞治療などの製品タイプがあり、皮膚科、心血管、中央神経系などの医療アプリケーションに利用されています。主要企業にはDePuy Synthes、Medtronic、ZimmerBiometなどがあり、2022年には上位2社が市場の大部分を占めています。
関連する質問
DePuy Synthes, Medtronic, ZimmerBiomet, Stryker, Acelity, MiMedx Group, Organogenesis, UniQure, Cellular Dynamics International, Osiris Therapeutics, Vcanbio, Gamida Cell, Golden Meditech, Cytori, Celgene, Vericel Corporation, Guanhao Biotech, Mesoblast, Stemcell Technologies, Bellicum Pharmaceuticals
特定の細胞への分化技術の進展, 主要企業の市場参入戦略, 地域別の市場シェアの変化
概要
LPI (LP Information)の最新の研究報告書「細胞治療再生医療産業予測」では、過去の販売状況を調査し、2022年の世界の細胞治療再生医療の総売上をレビューしています。この報告書では、2023年から2029年にかけての予測された細胞治療再生医療の売上を地域別および市場セクター別に包括的に分析しています。地域、市場セクター、サブセクターごとに細胞治療再生医療の売上が分析され、世界の細胞治療再生医療産業に関する詳細な分析をXX米ドル百万単位で提供。
このインサイトレポートは、世界の細胞治療再生医療の状況について包括的な分析を提供し、製品のセグメンテーション、企業の形成、収益、市場シェア、最新の開発、M&A活動に関連する主要なトレンドを強調しています。この報告書では、細胞治療再生医療ポートフォリオと能力、市場参入戦略、市場ポジション、地理的な足跡に焦点を当て、世界の細胞治療再生医療市場が加速する中で、これらの企業の独自の立ち位置をよりよく理解するために、主要なグローバル企業の戦略も分析しています。
このインサイトレポートは、細胞療法再生医療のグローバルな展望を形成する主要な市場動向、推進要因、および影響要因を評価し、タイプ、アプリケーション、地域、マーケットサイズによって予測を分解し、新たな機会のポケットを浮き彫りにしています。何百ものボトムアップによる定性的および定量的市場インプットに基づく透明な方法論を用いたこの研究予測は、グローバルな細胞療法再生医療の現在の状態と将来の軌跡について、非常に詳細な見解を提供します。
グローバル細胞治療再生医療市場の規模は、2022年のXX米ドルから2029年のXX米ドルに成長する見込みです。また、2023年から2029年の間にXX%の年平均成長率（CAGR）が予測されています。
アメリカの細胞治療再生医療市場は、2022年のXX米ドルから2029年にはXX米ドルに増加する見込みで、2023年から2029年の間にXX%の CAGRで成長します。
中国の細胞治療再生医療市場は、2022年のXX米ドルから2029年にはXX米ドルに増加すると推定されており、2023年から2029年の間にCAGRXX%となる見込みです。
欧州市場の細胞治療再生医療は、2022年のXX米ドルから2029年までにXX米ドルに増加すると推定されており、2023年から2029年の間にXX%のCAGRが予測されています。
グローバルな主要な細胞治療再生医療のプレーヤーは、デピュイ・シンセス、メドトロニック、ジマービオメット、ストライカー、アセリティ、ミメドックス・グループ、オルガノジェネシス、ユニキュア、セルラーダイナミクス・インターナショナルなどです。収益の面では、2022年において、グローバルで最も大きな2社がほぼXX%のシェアを占めました。
この報告書は、製品タイプ、アプリケーション、主要メーカー、および主要地域と国別の細胞治療再生医療市場の包括的な概要、市場シェア、および成長機会を提示しています。
市場セグメンテーション
タイプ別セグメンテーション
NK細胞療法
CAR-T細胞療法
その他
アプリケーション別のセグメンテーション
皮膚科
心血管
中枢神経系
美容整形
その他の医療用途
この報告は地域別に市場を分割しています。
アメリカ大陸
アメリカ合衆国
カナダ
メキシコ
ブラジル
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
中東およびアフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下にプロファイルされた企業は、一次専門家から収集した情報と企業のカバレッジ、製品ポートフォリオ、市場浸透率を分析した結果に基づいて選定されています。
デピュー・シンセス
メドトロニック
ジンバービオメット
ストライカー
アセリティ
ミメダックス・グループ
器官形成
ユニキュア
セルラー・ダイナミクス・インターナショナル
オシリス・セラピューティクス
Vcanbio
ガミダセル
ゴールデン・メディテック
サイトリ社
セルジーン
ベリセル・コーポレーション
グアンハオバイオテック
メソブラスト
ステムセルテクノロジーズ
ベリカム・ファーマシューティカルズ
本レポートで扱った主要な質問
グローバル細胞治療再生医療市場の10年見通しは何ですか？
細胞療法再生医療市場の成長を促進している要因は何ですか？グローバルおよび地域別に。
市場と地域別に、どの技術が最も急速な成長を遂げる見込みですか？
細胞治療再生医療市場の機会は、エンド市場のサイズによってどのように異なりますか？
細胞療法再生医療は、タイプおよびアプリケーションにおいてどのように分類されますか？
COVID-19とロシア・ウクライナ戦争の影響は何ですか？
※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
1 調査範囲
1.1 市場イントロダクション
1.2 対象年
1.3 調査目的
1.4 市場調査手法
1.5 調査プロセスとデータソース
1.6 経済指標
1.7 通貨
1.8 市場予測における留意事項
2 エグゼクティブサマリー
2.1 世界市場概要
2.1.1 グローバルの細胞治療再生医療、年間売上、2018年～2029年
2.1.2 細胞治療再生医療の世界市場の現状分析・将来予測、地理別、2018年、2022年および2029年
2.1.3 細胞治療再生医療の世界市場の現状分析・将来予測、国・地域別、2018年、2022年および2029年
2.2 細胞治療再生医療セグメント、タイプ別
2.2.1 NK細胞療法
2.2.2 CAR-T細胞療法
2.2.3 その他
2.3 細胞治療再生医療の売上、タイプ別
2.3.1 グローバルにおける細胞治療再生医療の売上・市場シェア、タイプ別（2018年～2023年）
2.3.2 細胞治療再生医療のグローバルレベニュー・市場シェア、タイプ別（2018～2023年）
2.3.3 グローバルの細胞治療再生医療、販売価格（タイプ別）（2018年～2023年）
2.4 細胞治療再生医療セグメント、用途別
2.4.1 皮膚科学
2.4.2 心血管系
2.4.3 中枢神経系
2.4.4 形成外科
2.4.5 その他の医療用アプリケーション
2.5 細胞治療再生医療の売上、用途別
2.5.1 グローバルの細胞治療再生医療、収益・市場シェア（用途別）（2018年～2023年）
2.5.2 細胞治療再生医療のグローバルレベニュー・市場シェア、用途別（2018～2023年）
2.5.3 グローバルの細胞治療再生医療、販売価格（用途別）（2018年～2023年）
3 グローバルにおける細胞治療再生医療、企業別
3.1 グローバルにおける細胞治療再生医療市場のブレークダウンデータ、企業別
3.1.1 グローバルにおける細胞治療再生医療の年間売上、企業別（2018年～2023年）
3.1.2 グローバルにおける細胞治療再生医療の売上・市場シェア、企業別（2018年～2023年）
3.2 グローバルにおける細胞治療再生医療の年間収益、企業別（2018年～2023年）
3.2.1 グローバルにおける細胞治療再生医療市場の収益規模、企業別（2018年～2023年）
3.2.2 グローバルにおける細胞治療再生医療市場の収益シェア、企業別（2018年～2023年）
3.3 グローバルにおける細胞治療再生医療の販売価格、企業別
3.4 細胞治療再生医療の主要メーカー、生産地域分布、販売地域、製品タイプ
3.4.1 細胞治療再生医療の主要メーカー、製品と拠点の分布
3.4.2 プレイヤーが提供している細胞治療再生医療製品
3.5 市場集中度分析
3.5.1 競合情勢分析
3.5.2 集中度レシオ（CR3、CR5、CR10）（2018年～2023年）
3.6 新製品・潜在的参入
3.7 M&A、拡大
4 細胞治療再生医療の世界市場過去推移レビュー、地理別
4.1 細胞治療再生医療の世界市場規模の過去推移、地理別（2018年～2023年）
4.1.1 グローバルにおける細胞治療再生医療の年間売上、地理別（2018年～2023年）
4.1.2 グローバルにおける細胞治療再生医療の年間収益、地理別（2018年～2023年）
4.2 細胞治療再生医療の世界市場規模の過去推移、国・地域別（2018年～2023年）
4.2.1 グローバルにおける細胞治療再生医療の年間売上、国・地域別（2018年～2023年）
4.2.2 グローバルにおける細胞治療再生医療の年間収益、国・地域別（2018年～2023年）
4.3 アメリカズにおける細胞治療再生医療の売上成長
4.4 APACにおける細胞治療再生医療の売上成長
4.5 ヨーロッパにおける細胞治療再生医療の売上成長
4.6 中東・アフリカにおける細胞治療再生医療の売上成長
5 アメリカズ
5.1 アメリカズにおける細胞治療再生医療の売上、国別
5.1.1 アメリカズにおける細胞治療再生医療の売上規模、国別（2018年～2023年）
5.1.2 アメリカズにおける細胞治療再生医療市場の収益規模、国別（2018年～2023年）
5.2 アメリカズにおける細胞治療再生医療の売上、タイプ別
5.3 アメリカズにおける細胞治療再生医療の売上、用途別
5.4 米国
5.5 カナダ
5.6 メキシコ
5.7 ブラジル
6 APAC
6.1 APACにおける細胞治療再生医療の売上、地域別
6.1.1 APACにおける細胞治療再生医療の売上規模、地域別（2018年～2023年）
6.1.2 APACにおける細胞治療再生医療市場の収益規模、地域別（2018年～2023年）
6.2 APACにおける細胞治療再生医療の売上、タイプ別
6.3 APACにおける細胞治療再生医療の売上、用途別
6.4 中国
6.5 日本
6.6 韓国
6.7 東南アジア
6.8 インド
6.9 オーストラリア
6.10 中国の台湾
7 ヨーロッパ
7.1 ヨーロッパにおける細胞治療再生医療、国別
7.1.1 ヨーロッパにおける細胞治療再生医療の売上規模、国別（2018年～2023年）
7.1.2 ヨーロッパにおける細胞治療再生医療市場の収益規模、国別（2018年～2023年）
7.2 ヨーロッパにおける細胞治療再生医療の売上、タイプ別
7.3 ヨーロッパにおける細胞治療再生医療の売上、用途別
7.4 ドイツ
7.5 フランス
7.6 英国
7.7 イタリア
7.8 ロシア
8 中東・アフリカ
8.1 中東・アフリカにおける細胞治療再生医療、国別
8.1.1 中東・アフリカにおける細胞治療再生医療の売上規模、国別（2018年～2023年）
8.1.2 中東・アフリカにおける細胞治療再生医療市場の収益規模、国別（2018年～2023年）
8.2 中東・アフリカにおける細胞治療再生医療の売上、タイプ別
8.3 中東・アフリカにおける細胞治療再生医療の売上、用途別
8.4 エジプト
8.5 南アフリカ
8.6 イスラエル
8.7 トルコ
8.8 GCC地域
9 市場ドライバー・課題・トレンド
9.1 市場ドライバー・成長機会
9.2 市場課題・リスク
9.3 業界トレンド
10 製造コスト構造分析
10.1 原料・サプライヤー
10.2 細胞治療再生医療の製造コスト構造分析
10.3 細胞治療再生医療の製造プロセス分析
10.4 細胞治療再生医療のインダストリーチェーン構造
11 マーケティング・流通・顧客
11.1 販売チャネル
11.1.1 直接チャネル
11.1.2 間接チャネル
11.2 細胞治療再生医療の流通業者
11.3 細胞治療再生医療の顧客
12 細胞治療再生医療の世界市場予測レビュー、地理別
12.1 グローバルにおける細胞治療再生医療の市場規模予測、地域別
12.1.1 グローバルの細胞治療再生医療、市場予測（地域別）（2024年～2029年）
12.1.2 グローバルの細胞治療再生医療、年間収益予測（地域別）（2024年～2029年）
12.2 アメリカズにおける予測、国別
12.3 APACにおける予測、地域別
12.4 ヨーロッパにおける予測、国別
12.5 中東・アフリカにおける予測、国別
12.6 グローバルにおける細胞治療再生医療の市場予測、タイプ別
12.7 グローバルにおける細胞治療再生医療の市場予測、用途別
13 キープレイヤー分析
13.1 DePuy Synthes
13.1.1 DePuy Synthes：企業情報
13.1.2 DePuy Synthes：細胞治療再生医療製品ポートフォリオと特徴
13.1.3 DePuy Synthes：細胞治療再生医療売上・収益・価格およびグロスマージン（2018年～2023年）
13.1.4 DePuy Synthes：主要事業概要
13.1.5 DePuy Synthes：直近の展開
13.2 Medtronic
13.2.1 Medtronic：企業情報
13.2.2 Medtronic：細胞治療再生医療製品ポートフォリオと特徴
13.2.3 Medtronic：細胞治療再生医療売上・収益・価格およびグロスマージン（2018年～2023年）
13.2.4 Medtronic：主要事業概要
13.2.5 Medtronic：直近の展開
13.3 ZimmerBiomet
13.3.1 ZimmerBiomet：企業情報
13.3.2 ZimmerBiomet：細胞治療再生医療製品ポートフォリオと特徴
13.3.3 ZimmerBiomet：細胞治療再生医療売上・収益・価格およびグロスマージン（2018年～2023年）
13.3.4 ZimmerBiomet：主要事業概要
13.3.5 ZimmerBiomet：直近の展開
13.4 Stryker
13.4.1 Stryker：企業情報
13.4.2 Stryker：細胞治療再生医療製品ポートフォリオと特徴
13.4.3 Stryker：細胞治療再生医療売上・収益・価格およびグロスマージン（2018年～2023年）
13.4.4 Stryker：主要事業概要
13.4.5 Stryker：直近の展開
13.5 Acelity
13.5.1 Acelity：企業情報
13.5.2 Acelity：細胞治療再生医療製品ポートフォリオと特徴
13.5.3 Acelity：細胞治療再生医療売上・収益・価格およびグロスマージン（2018年～2023年）
13.5.4 Acelity：主要事業概要
13.5.5 Acelity：直近の展開
13.6 MiMedx Group
13.6.1 MiMedx Group：企業情報
13.6.2 MiMedx Group：細胞治療再生医療製品ポートフォリオと特徴
13.6.3 MiMedx Group：細胞治療再生医療売上・収益・価格およびグロスマージン（2018年～2023年）
13.6.4 MiMedx Group：主要事業概要
13.6.5 MiMedx Group：直近の展開
13.7 Organogenesis
13.7.1 Organogenesis：企業情報
13.7.2 Organogenesis：細胞治療再生医療製品ポートフォリオと特徴
13.7.3 Organogenesis：細胞治療再生医療売上・収益・価格およびグロスマージン（2018年～2023年）
13.7.4 Organogenesis：主要事業概要
13.7.5 Organogenesis：直近の展開
13.8 UniQure
13.8.1 UniQure：企業情報
13.8.2 UniQure：細胞治療再生医療製品ポートフォリオと特徴
13.8.3 UniQure：細胞治療再生医療売上・収益・価格およびグロスマージン（2018年～2023年）
13.8.4 UniQure：主要事業概要
13.8.5 UniQure：直近の展開
13.9 Cellular Dynamics International
13.9.1 Cellular Dynamics International：企業情報
13.9.2 Cellular Dynamics International：細胞治療再生医療製品ポートフォリオと特徴
13.9.3 Cellular Dynamics International：細胞治療再生医療売上・収益・価格およびグロスマージン（2018年～2023年）
13.9.4 Cellular Dynamics International：主要事業概要
13.9.5 Cellular Dynamics International：直近の展開
13.10 Osiris Therapeutics
13.10.1 Osiris Therapeutics：企業情報
13.10.2 Osiris Therapeutics：細胞治療再生医療製品ポートフォリオと特徴
13.10.3 Osiris Therapeutics：細胞治療再生医療売上・収益・価格およびグロスマージン（2018年～2023年）
13.10.4 Osiris Therapeutics：主要事業概要
13.10.5 Osiris Therapeutics：直近の展開
13.11 Vcanbio
13.11.1 Vcanbio：企業情報
13.11.2 Vcanbio：細胞治療再生医療製品ポートフォリオと特徴
13.11.3 Vcanbio：細胞治療再生医療売上・収益・価格およびグロスマージン（2018年～2023年）
13.11.4 Vcanbio：主要事業概要
13.11.5 Vcanbio：直近の展開
13.12 Gamida Cell
13.12.1 Gamida Cell：企業情報
13.12.2 Gamida Cell：細胞治療再生医療製品ポートフォリオと特徴
13.12.3 Gamida Cell：細胞治療再生医療売上・収益・価格およびグロスマージン（2018年～2023年）
13.12.4 Gamida Cell：主要事業概要
13.12.5 Gamida Cell：直近の展開
13.13 Golden Meditech
13.13.1 Golden Meditech：企業情報
13.13.2 Golden Meditech：細胞治療再生医療製品ポートフォリオと特徴
13.13.3 Golden Meditech：細胞治療再生医療売上・収益・価格およびグロスマージン（2018年～2023年）
13.13.4 Golden Meditech：主要事業概要
13.13.5 Golden Meditech：直近の展開
13.14 Cytori
13.14.1 Cytori：企業情報
13.14.2 Cytori：細胞治療再生医療製品ポートフォリオと特徴
13.14.3 Cytori：細胞治療再生医療売上・収益・価格およびグロスマージン（2018年～2023年）
13.14.4 Cytori：主要事業概要
13.14.5 Cytori：直近の展開
13.15 Celgene
13.15.1 Celgene：企業情報
13.15.2 Celgene：細胞治療再生医療製品ポートフォリオと特徴
13.15.3 Celgene：細胞治療再生医療売上・収益・価格およびグロスマージン（2018年～2023年）
13.15.4 Celgene：主要事業概要
13.15.5 Celgene：直近の展開
13.16 Vericel Corporation
13.16.1 Vericel Corporation：企業情報
13.16.2 Vericel Corporation：細胞治療再生医療製品ポートフォリオと特徴
13.16.3 Vericel Corporation：細胞治療再生医療売上・収益・価格およびグロスマージン（2018年～2023年）
13.16.4 Vericel Corporation：主要事業概要
13.16.5 Vericel Corporation：直近の展開
13.17 Guanhao Biotech
13.17.1 Guanhao Biotech：企業情報
13.17.2 Guanhao Biotech：細胞治療再生医療製品ポートフォリオと特徴
13.17.3 Guanhao Biotech：細胞治療再生医療売上・収益・価格およびグロスマージン（2018年～2023年）
13.17.4 Guanhao Biotech：主要事業概要
13.17.5 Guanhao Biotech：直近の展開
13.18 Mesoblast
13.18.1 Mesoblast：企業情報
13.18.2 Mesoblast：細胞治療再生医療製品ポートフォリオと特徴
13.18.3 Mesoblast：細胞治療再生医療売上・収益・価格およびグロスマージン（2018年～2023年）
13.18.4 Mesoblast：主要事業概要
13.18.5 Mesoblast：直近の展開
13.19 Stemcell Technologies
13.19.1 Stemcell Technologies：企業情報
13.19.2 Stemcell Technologies：細胞治療再生医療製品ポートフォリオと特徴
13.19.3 Stemcell Technologies：細胞治療再生医療売上・収益・価格およびグロスマージン（2018年～2023年）
13.19.4 Stemcell Technologies：主要事業概要
13.19.5 Stemcell Technologies：直近の展開
13.20 Bellicum Pharmaceuticals
13.20.1 Bellicum Pharmaceuticals：企業情報
13.20.2 Bellicum Pharmaceuticals：細胞治療再生医療製品ポートフォリオと特徴
13.20.3 Bellicum Pharmaceuticals：細胞治療再生医療売上・収益・価格およびグロスマージン（2018年～2023年）
13.20.4 Bellicum Pharmaceuticals：主要事業概要
13.20.5 Bellicum Pharmaceuticals：直近の展開
14 調査の結果・結論
※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”
Description
LPI (LP Information)' newest research report, the “Cell Therapy Regenerative Medicine Industry Forecast” looks at past sales and reviews total world Cell Therapy Regenerative Medicine sales in 2022, providing a comprehensive analysis by region and market sector of projected Cell Therapy Regenerative Medicine sales for 2023 through 2029. With Cell Therapy Regenerative Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell Therapy Regenerative Medicine industry.
This Insight Report provides a comprehensive analysis of the global Cell Therapy Regenerative Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cell Therapy Regenerative Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Cell Therapy Regenerative Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell Therapy Regenerative Medicine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell Therapy Regenerative Medicine.
The global Cell Therapy Regenerative Medicine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Cell Therapy Regenerative Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Cell Therapy Regenerative Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Cell Therapy Regenerative Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Cell Therapy Regenerative Medicine players cover DePuy Synthes, Medtronic, ZimmerBiomet, Stryker, Acelity, MiMedx Group, Organogenesis, UniQure and Cellular Dynamics International, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell Therapy Regenerative Medicine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
NK Cell Therapy
CAR-T Cell Therapy
Others
Segmentation by application
Dermatology
Cardiovascular
Central Nervous System
Plastic Surgery
Other Medical Applications
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
DePuy Synthes
Medtronic
ZimmerBiomet
Stryker
Acelity
MiMedx Group
Organogenesis
UniQure
Cellular Dynamics International
Osiris Therapeutics
Vcanbio
Gamida Cell
Golden Meditech
Cytori
Celgene
Vericel Corporation
Guanhao Biotech
Mesoblast
Stemcell Technologies
Bellicum Pharmaceuticals
Key Questions Addressed in this Report
What is the 10-year outlook for the global Cell Therapy Regenerative Medicine market?
What factors are driving Cell Therapy Regenerative Medicine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Cell Therapy Regenerative Medicine market opportunities vary by end market size?
How does Cell Therapy Regenerative Medicine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cell Therapy Regenerative Medicine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Cell Therapy Regenerative Medicine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Cell Therapy Regenerative Medicine by Country/Region, 2018, 2022 & 2029
2.2 Cell Therapy Regenerative Medicine Segment by Type
2.2.1 NK Cell Therapy
2.2.2 CAR-T Cell Therapy
2.2.3 Others
2.3 Cell Therapy Regenerative Medicine Sales by Type
2.3.1 Global Cell Therapy Regenerative Medicine Sales Market Share by Type (2018-2023)
2.3.2 Global Cell Therapy Regenerative Medicine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Cell Therapy Regenerative Medicine Sale Price by Type (2018-2023)
2.4 Cell Therapy Regenerative Medicine Segment by Application
2.4.1 Dermatology
2.4.2 Cardiovascular
2.4.3 Central Nervous System
2.4.4 Plastic Surgery
2.4.5 Other Medical Applications
2.5 Cell Therapy Regenerative Medicine Sales by Application
2.5.1 Global Cell Therapy Regenerative Medicine Sale Market Share by Application (2018-2023)
2.5.2 Global Cell Therapy Regenerative Medicine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Cell Therapy Regenerative Medicine Sale Price by Application (2018-2023)
3 Global Cell Therapy Regenerative Medicine by Company
3.1 Global Cell Therapy Regenerative Medicine Breakdown Data by Company
3.1.1 Global Cell Therapy Regenerative Medicine Annual Sales by Company (2018-2023)
3.1.2 Global Cell Therapy Regenerative Medicine Sales Market Share by Company (2018-2023)
3.2 Global Cell Therapy Regenerative Medicine Annual Revenue by Company (2018-2023)
3.2.1 Global Cell Therapy Regenerative Medicine Revenue by Company (2018-2023)
3.2.2 Global Cell Therapy Regenerative Medicine Revenue Market Share by Company (2018-2023)
3.3 Global Cell Therapy Regenerative Medicine Sale Price by Company
3.4 Key Manufacturers Cell Therapy Regenerative Medicine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cell Therapy Regenerative Medicine Product Location Distribution
3.4.2 Players Cell Therapy Regenerative Medicine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Cell Therapy Regenerative Medicine by Geographic Region
4.1 World Historic Cell Therapy Regenerative Medicine Market Size by Geographic Region (2018-2023)
4.1.1 Global Cell Therapy Regenerative Medicine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Cell Therapy Regenerative Medicine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Cell Therapy Regenerative Medicine Market Size by Country/Region (2018-2023)
4.2.1 Global Cell Therapy Regenerative Medicine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Cell Therapy Regenerative Medicine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Cell Therapy Regenerative Medicine Sales Growth
4.4 APAC Cell Therapy Regenerative Medicine Sales Growth
4.5 Europe Cell Therapy Regenerative Medicine Sales Growth
4.6 Middle East & Africa Cell Therapy Regenerative Medicine Sales Growth
5 Americas
5.1 Americas Cell Therapy Regenerative Medicine Sales by Country
5.1.1 Americas Cell Therapy Regenerative Medicine Sales by Country (2018-2023)
5.1.2 Americas Cell Therapy Regenerative Medicine Revenue by Country (2018-2023)
5.2 Americas Cell Therapy Regenerative Medicine Sales by Type
5.3 Americas Cell Therapy Regenerative Medicine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell Therapy Regenerative Medicine Sales by Region
6.1.1 APAC Cell Therapy Regenerative Medicine Sales by Region (2018-2023)
6.1.2 APAC Cell Therapy Regenerative Medicine Revenue by Region (2018-2023)
6.2 APAC Cell Therapy Regenerative Medicine Sales by Type
6.3 APAC Cell Therapy Regenerative Medicine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Cell Therapy Regenerative Medicine by Country
7.1.1 Europe Cell Therapy Regenerative Medicine Sales by Country (2018-2023)
7.1.2 Europe Cell Therapy Regenerative Medicine Revenue by Country (2018-2023)
7.2 Europe Cell Therapy Regenerative Medicine Sales by Type
7.3 Europe Cell Therapy Regenerative Medicine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cell Therapy Regenerative Medicine by Country
8.1.1 Middle East & Africa Cell Therapy Regenerative Medicine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Cell Therapy Regenerative Medicine Revenue by Country (2018-2023)
8.2 Middle East & Africa Cell Therapy Regenerative Medicine Sales by Type
8.3 Middle East & Africa Cell Therapy Regenerative Medicine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cell Therapy Regenerative Medicine
10.3 Manufacturing Process Analysis of Cell Therapy Regenerative Medicine
10.4 Industry Chain Structure of Cell Therapy Regenerative Medicine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cell Therapy Regenerative Medicine Distributors
11.3 Cell Therapy Regenerative Medicine Customer
12 World Forecast Review for Cell Therapy Regenerative Medicine by Geographic Region
12.1 Global Cell Therapy Regenerative Medicine Market Size Forecast by Region
12.1.1 Global Cell Therapy Regenerative Medicine Forecast by Region (2024-2029)
12.1.2 Global Cell Therapy Regenerative Medicine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Cell Therapy Regenerative Medicine Forecast by Type
12.7 Global Cell Therapy Regenerative Medicine Forecast by Application
13 Key Players Analysis
13.1 DePuy Synthes
13.1.1 DePuy Synthes Company Information
13.1.2 DePuy Synthes Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.1.3 DePuy Synthes Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 DePuy Synthes Main Business Overview
13.1.5 DePuy Synthes Latest Developments
13.2 Medtronic
13.2.1 Medtronic Company Information
13.2.2 Medtronic Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.2.3 Medtronic Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Medtronic Main Business Overview
13.2.5 Medtronic Latest Developments
13.3 ZimmerBiomet
13.3.1 ZimmerBiomet Company Information
13.3.2 ZimmerBiomet Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.3.3 ZimmerBiomet Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 ZimmerBiomet Main Business Overview
13.3.5 ZimmerBiomet Latest Developments
13.4 Stryker
13.4.1 Stryker Company Information
13.4.2 Stryker Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.4.3 Stryker Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Stryker Main Business Overview
13.4.5 Stryker Latest Developments
13.5 Acelity
13.5.1 Acelity Company Information
13.5.2 Acelity Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.5.3 Acelity Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Acelity Main Business Overview
13.5.5 Acelity Latest Developments
13.6 MiMedx Group
13.6.1 MiMedx Group Company Information
13.6.2 MiMedx Group Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.6.3 MiMedx Group Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 MiMedx Group Main Business Overview
13.6.5 MiMedx Group Latest Developments
13.7 Organogenesis
13.7.1 Organogenesis Company Information
13.7.2 Organogenesis Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.7.3 Organogenesis Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Organogenesis Main Business Overview
13.7.5 Organogenesis Latest Developments
13.8 UniQure
13.8.1 UniQure Company Information
13.8.2 UniQure Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.8.3 UniQure Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 UniQure Main Business Overview
13.8.5 UniQure Latest Developments
13.9 Cellular Dynamics International
13.9.1 Cellular Dynamics International Company Information
13.9.2 Cellular Dynamics International Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.9.3 Cellular Dynamics International Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Cellular Dynamics International Main Business Overview
13.9.5 Cellular Dynamics International Latest Developments
13.10 Osiris Therapeutics
13.10.1 Osiris Therapeutics Company Information
13.10.2 Osiris Therapeutics Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.10.3 Osiris Therapeutics Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Osiris Therapeutics Main Business Overview
13.10.5 Osiris Therapeutics Latest Developments
13.11 Vcanbio
13.11.1 Vcanbio Company Information
13.11.2 Vcanbio Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.11.3 Vcanbio Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Vcanbio Main Business Overview
13.11.5 Vcanbio Latest Developments
13.12 Gamida Cell
13.12.1 Gamida Cell Company Information
13.12.2 Gamida Cell Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.12.3 Gamida Cell Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Gamida Cell Main Business Overview
13.12.5 Gamida Cell Latest Developments
13.13 Golden Meditech
13.13.1 Golden Meditech Company Information
13.13.2 Golden Meditech Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.13.3 Golden Meditech Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Golden Meditech Main Business Overview
13.13.5 Golden Meditech Latest Developments
13.14 Cytori
13.14.1 Cytori Company Information
13.14.2 Cytori Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.14.3 Cytori Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Cytori Main Business Overview
13.14.5 Cytori Latest Developments
13.15 Celgene
13.15.1 Celgene Company Information
13.15.2 Celgene Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.15.3 Celgene Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Celgene Main Business Overview
13.15.5 Celgene Latest Developments
13.16 Vericel Corporation
13.16.1 Vericel Corporation Company Information
13.16.2 Vericel Corporation Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.16.3 Vericel Corporation Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Vericel Corporation Main Business Overview
13.16.5 Vericel Corporation Latest Developments
13.17 Guanhao Biotech
13.17.1 Guanhao Biotech Company Information
13.17.2 Guanhao Biotech Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.17.3 Guanhao Biotech Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Guanhao Biotech Main Business Overview
13.17.5 Guanhao Biotech Latest Developments
13.18 Mesoblast
13.18.1 Mesoblast Company Information
13.18.2 Mesoblast Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.18.3 Mesoblast Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Mesoblast Main Business Overview
13.18.5 Mesoblast Latest Developments
13.19 Stemcell Technologies
13.19.1 Stemcell Technologies Company Information
13.19.2 Stemcell Technologies Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.19.3 Stemcell Technologies Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Stemcell Technologies Main Business Overview
13.19.5 Stemcell Technologies Latest Developments
13.20 Bellicum Pharmaceuticals
13.20.1 Bellicum Pharmaceuticals Company Information
13.20.2 Bellicum Pharmaceuticals Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.20.3 Bellicum Pharmaceuticals Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Bellicum Pharmaceuticals Main Business Overview
13.20.5 Bellicum Pharmaceuticals Latest Developments
14 Research Findings and Conclusion
List of Tables Table 1. Cell Therapy Regenerative Medicine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions) Table 2. Cell Therapy Regenerative Medicine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions) Table 3. Major Players of NK Cell Therapy Table 4. Major Players of CAR-T Cell Therapy Table 5. Major Players of Others Table 6. Global Cell Therapy Regenerative Medicine Sales by Type (2018-2023) & (K Units) Table 7. Global Cell Therapy Regenerative Medicine Sales Market Share by Type (2018-2023) Table 8. Global Cell Therapy Regenerative Medicine Revenue by Type (2018-2023) & ($ million) Table 9. Global Cell Therapy Regenerative Medicine Revenue Market Share by Type (2018-2023) Table 10. Global Cell Therapy Regenerative Medicine Sale Price by Type (2018-2023) & (US$/Unit) Table 11. Global Cell Therapy Regenerative Medicine Sales by Application (2018-2023) & (K Units) Table 12. Global Cell Therapy Regenerative Medicine Sales Market Share by Application (2018-2023) Table 13. Global Cell Therapy Regenerative Medicine Revenue by Application (2018-2023) Table 14. Global Cell Therapy Regenerative Medicine Revenue Market Share by Application (2018-2023) Table 15. Global Cell Therapy Regenerative Medicine Sale Price by Application (2018-2023) & (US$/Unit) Table 16. Global Cell Therapy Regenerative Medicine Sales by Company (2018-2023) & (K Units) Table 17. Global Cell Therapy Regenerative Medicine Sales Market Share by Company (2018-2023) Table 18. Global Cell Therapy Regenerative Medicine Revenue by Company (2018-2023) ($ Millions) Table 19. Global Cell Therapy Regenerative Medicine Revenue Market Share by Company (2018-2023) Table 20. Global Cell Therapy Regenerative Medicine Sale Price by Company (2018-2023) & (US$/Unit) Table 21. Key Manufacturers Cell Therapy Regenerative Medicine Producing Area Distribution and Sales Area Table 22. Players Cell Therapy Regenerative Medicine Products Offered Table 23. Cell Therapy Regenerative Medicine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) Table 24. New Products and Potential Entrants Table 25. Mergers & Acquisitions, Expansion Table 26. Global Cell Therapy Regenerative Medicine Sales by Geographic Region (2018-2023) & (K Units) Table 27. Global Cell Therapy Regenerative Medicine Sales Market Share Geographic Region (2018-2023) Table 28. Global Cell Therapy Regenerative Medicine Revenue by Geographic Region (2018-2023) & ($ millions) Table 29. Global Cell Therapy Regenerative Medicine Revenue Market Share by Geographic Region (2018-2023) Table 30. Global Cell Therapy Regenerative Medicine Sales by Country/Region (2018-2023) & (K Units) Table 31. Global Cell Therapy Regenerative Medicine Sales Market Share by Country/Region (2018-2023) Table 32. Global Cell Therapy Regenerative Medicine Revenue by Country/Region (2018-2023) & ($ millions) Table 33. Global Cell Therapy Regenerative Medicine Revenue Market Share by Country/Region (2018-2023) Table 34. Americas Cell Therapy Regenerative Medicine Sales by Country (2018-2023) & (K Units) Table 35. Americas Cell Therapy Regenerative Medicine Sales Market Share by Country (2018-2023) Table 36. Americas Cell Therapy Regenerative Medicine Revenue by Country (2018-2023) & ($ Millions) Table 37. Americas Cell Therapy Regenerative Medicine Revenue Market Share by Country (2018-2023) Table 38. Americas Cell Therapy Regenerative Medicine Sales by Type (2018-2023) & (K Units) Table 39. Americas Cell Therapy Regenerative Medicine Sales by Application (2018-2023) & (K Units) Table 40. APAC Cell Therapy Regenerative Medicine Sales by Region (2018-2023) & (K Units) Table 41. APAC Cell Therapy Regenerative Medicine Sales Market Share by Region (2018-2023) Table 42. APAC Cell Therapy Regenerative Medicine Revenue by Region (2018-2023) & ($ Millions) Table 43. APAC Cell Therapy Regenerative Medicine Revenue Market Share by Region (2018-2023) Table 44. APAC Cell Therapy Regenerative Medicine Sales by Type (2018-2023) & (K Units) Table 45. APAC Cell Therapy Regenerative Medicine Sales by Application (2018-2023) & (K Units) Table 46. Europe Cell Therapy Regenerative Medicine Sales by Country (2018-2023) & (K Units) Table 47. Europe Cell Therapy Regenerative Medicine Sales Market Share by Country (2018-2023) Table 48. Europe Cell Therapy Regenerative Medicine Revenue by Country (2018-2023) & ($ Millions) Table 49. Europe Cell Therapy Regenerative Medicine Revenue Market Share by Country (2018-2023) Table 50. Europe Cell Therapy Regenerative Medicine Sales by Type (2018-2023) & (K Units) Table 51. Europe Cell Therapy Regenerative Medicine Sales by Application (2018-2023) & (K Units) Table 52. Middle East & Africa Cell Therapy Regenerative Medicine Sales by Country (2018-2023) & (K Units) Table 53. Middle East & Africa Cell Therapy Regenerative Medicine Sales Market Share by Country (2018-2023) Table 54. Middle East & Africa Cell Therapy Regenerative Medicine Revenue by Country (2018-2023) & ($ Millions) Table 55. Middle East & Africa Cell Therapy Regenerative Medicine Revenue Market Share by Country (2018-2023) Table 56. Middle East & Africa Cell Therapy Regenerative Medicine Sales by Type (2018-2023) & (K Units) Table 57. Middle East & Africa Cell Therapy Regenerative Medicine Sales by Application (2018-2023) & (K Units) Table 58. Key Market Drivers & Growth Opportunities of Cell Therapy Regenerative Medicine Table 59. Key Market Challenges & Risks of Cell Therapy Regenerative Medicine Table 60. Key Industry Trends of Cell Therapy Regenerative Medicine Table 61. Cell Therapy Regenerative Medicine Raw Material Table 62. Key Suppliers of Raw Materials Table 63. Cell Therapy Regenerative Medicine Distributors List Table 64. Cell Therapy Regenerative Medicine Customer List Table 65. Global Cell Therapy Regenerative Medicine Sales Forecast by Region (2024-2029) & (K Units) Table 66. Global Cell Therapy Regenerative Medicine Revenue Forecast by Region (2024-2029) & ($ millions) Table 67. Americas Cell Therapy Regenerative Medicine Sales Forecast by Country (2024-2029) & (K Units) Table 68. Americas Cell Therapy Regenerative Medicine Revenue Forecast by Country (2024-2029) & ($ millions) Table 69. APAC Cell Therapy Regenerative Medicine Sales Forecast by Region (2024-2029) & (K Units) Table 70. APAC Cell Therapy Regenerative Medicine Revenue Forecast by Region (2024-2029) & ($ millions) Table 71. Europe Cell Therapy Regenerative Medicine Sales Forecast by Country (2024-2029) & (K Units) Table 72. Europe Cell Therapy Regenerative Medicine Revenue Forecast by Country (2024-2029) & ($ millions) Table 73. Middle East & Africa Cell Therapy Regenerative Medicine Sales Forecast by Country (2024-2029) & (K Units) Table 74. Middle East & Africa Cell Therapy Regenerative Medicine Revenue Forecast by Country (2024-2029) & ($ millions) Table 75. Global Cell Therapy Regenerative Medicine Sales Forecast by Type (2024-2029) & (K Units) Table 76. Global Cell Therapy Regenerative Medicine Revenue Forecast by Type (2024-2029) & ($ Millions) Table 77. Global Cell Therapy Regenerative Medicine Sales Forecast by Application (2024-2029) & (K Units) Table 78. Global Cell Therapy Regenerative Medicine Revenue Forecast by Application (2024-2029) & ($ Millions) Table 79. DePuy Synthes Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors Table 80. DePuy Synthes Cell Therapy Regenerative Medicine Product Portfolios and Specifications Table 81. DePuy Synthes Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 82. DePuy Synthes Main Business Table 83. DePuy Synthes Latest Developments Table 84. Medtronic Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors Table 85. Medtronic Cell Therapy Regenerative Medicine Product Portfolios and Specifications Table 86. Medtronic Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 87. Medtronic Main Business Table 88. Medtronic Latest Developments Table 89. ZimmerBiomet Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors Table 90. ZimmerBiomet Cell Therapy Regenerative Medicine Product Portfolios and Specifications Table 91. ZimmerBiomet Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 92. ZimmerBiomet Main Business Table 93. ZimmerBiomet Latest Developments Table 94. Stryker Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors Table 95. Stryker Cell Therapy Regenerative Medicine Product Portfolios and Specifications Table 96. Stryker Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 97. Stryker Main Business Table 98. Stryker Latest Developments Table 99. Acelity Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors Table 100. Acelity Cell Therapy Regenerative Medicine Product Portfolios and Specifications Table 101. Acelity Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 102. Acelity Main Business Table 103. Acelity Latest Developments Table 104. MiMedx Group Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors Table 105. MiMedx Group Cell Therapy Regenerative Medicine Product Portfolios and Specifications Table 106. MiMedx Group Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 107. MiMedx Group Main Business Table 108. MiMedx Group Latest Developments Table 109. Organogenesis Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors Table 110. Organogenesis Cell Therapy Regenerative Medicine Product Portfolios and Specifications Table 111. Organogenesis Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 112. Organogenesis Main Business Table 113. Organogenesis Latest Developments Table 114. UniQure Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors Table 115. UniQure Cell Therapy Regenerative Medicine Product Portfolios and Specifications Table 116. UniQure Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 117. UniQure Main Business Table 118. UniQure Latest Developments Table 119. Cellular Dynamics International Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors Table 120. Cellular Dynamics International Cell Therapy Regenerative Medicine Product Portfolios and Specifications Table 121. Cellular Dynamics International Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 122. Cellular Dynamics International Main Business Table 123. Cellular Dynamics International Latest Developments Table 124. Osiris Therapeutics Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors Table 125. Osiris Therapeutics Cell Therapy Regenerative Medicine Product Portfolios and Specifications Table 126. Osiris Therapeutics Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 127. Osiris Therapeutics Main Business Table 128. Osiris Therapeutics Latest Developments Table 129. Vcanbio Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors Table 130. Vcanbio Cell Therapy Regenerative Medicine Product Portfolios and Specifications Table 131. Vcanbio Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 132. Vcanbio Main Business Table 133. Vcanbio Latest Developments Table 134. Gamida Cell Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors Table 135. Gamida Cell Cell Therapy Regenerative Medicine Product Portfolios and Specifications Table 136. Gamida Cell Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 137. Gamida Cell Main Business Table 138. Gamida Cell Latest Developments Table 139. Golden Meditech Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors Table 140. Golden Meditech Cell Therapy Regenerative Medicine Product Portfolios and Specifications Table 141. Golden Meditech Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 142. Golden Meditech Main Business Table 143. Golden Meditech Latest Developments Table 144. Cytori Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors Table 145. Cytori Cell Therapy Regenerative Medicine Product Portfolios and Specifications Table 146. Cytori Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 147. Cytori Main Business Table 148. Cytori Latest Developments Table 149. Celgene Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors Table 150. Celgene Cell Therapy Regenerative Medicine Product Portfolios and Specifications Table 151. Celgene Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 152. Celgene Main Business Table 153. Celgene Latest Developments Table 154. Vericel Corporation Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors Table 155. Vericel Corporation Cell Therapy Regenerative Medicine Product Portfolios and Specifications Table 156. Vericel Corporation Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 157. Vericel Corporation Main Business Table 158. Vericel Corporation Latest Developments Table 159. Guanhao Biotech Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors Table 160. Guanhao Biotech Cell Therapy Regenerative Medicine Product Portfolios and Specifications Table 161. Guanhao Biotech Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 162. Guanhao Biotech Main Business Table 163. Guanhao Biotech Latest Developments Table 164. Mesoblast Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors Table 165. Mesoblast Cell Therapy Regenerative Medicine Product Portfolios and Specifications Table 166. Mesoblast Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 167. Mesoblast Main Business Table 168. Mesoblast Latest Developments Table 169. Stemcell Technologies Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors Table 170. Stemcell Technologies Cell Therapy Regenerative Medicine Product Portfolios and Specifications Table 171. Stemcell Technologies Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 172. Stemcell Technologies Main Business Table 173. Stemcell Technologies Latest Developments Table 174. Bellicum Pharmaceuticals Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors Table 175. Bellicum Pharmaceuticals Cell Therapy Regenerative Medicine Product Portfolios and Specifications Table 176. Bellicum Pharmaceuticals Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 177. Bellicum Pharmaceuticals Main Business Table 178. Bellicum Pharmaceuticals Latest Developments List of Figures Figure 1. Picture of Cell Therapy Regenerative Medicine Figure 2. Cell Therapy Regenerative Medicine Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Cell Therapy Regenerative Medicine Sales Growth Rate 2018-2029 (K Units) Figure 7. Global Cell Therapy Regenerative Medicine Revenue Growth Rate 2018-2029 ($ Millions) Figure 8. Cell Therapy Regenerative Medicine Sales by Region (2018, 2022 & 2029) & ($ Millions) Figure 9. Product Picture of NK Cell Therapy Figure 10. Product Picture of CAR-T Cell Therapy Figure 11. Product Picture of Others Figure 12. Global Cell Therapy Regenerative Medicine Sales Market Share by Type in 2022 Figure 13. Global Cell Therapy Regenerative Medicine Revenue Market Share by Type (2018-2023) Figure 14. Cell Therapy Regenerative Medicine Consumed in Dermatology Figure 15. Global Cell Therapy Regenerative Medicine Market: Dermatology (2018-2023) & (K Units) Figure 16. Cell Therapy Regenerative Medicine Consumed in Cardiovascular Figure 17. Global Cell Therapy Regenerative Medicine Market: Cardiovascular (2018-2023) & (K Units) Figure 18. Cell Therapy Regenerative Medicine Consumed in Central Nervous System Figure 19. Global Cell Therapy Regenerative Medicine Market: Central Nervous System (2018-2023) & (K Units) Figure 20. Cell Therapy Regenerative Medicine Consumed in Plastic Surgery Figure 21. Global Cell Therapy Regenerative Medicine Market: Plastic Surgery (2018-2023) & (K Units) Figure 22. Cell Therapy Regenerative Medicine Consumed in Other Medical Applications Figure 23. Global Cell Therapy Regenerative Medicine Market: Other Medical Applications (2018-2023) & (K Units) Figure 24. Global Cell Therapy Regenerative Medicine Sales Market Share by Application (2022) Figure 25. Global Cell Therapy Regenerative Medicine Revenue Market Share by Application in 2022 Figure 26. Cell Therapy Regenerative Medicine Sales Market by Company in 2022 (K Units) Figure 27. Global Cell Therapy Regenerative Medicine Sales Market Share by Company in 2022 Figure 28. Cell Therapy Regenerative Medicine Revenue Market by Company in 2022 ($ Million) Figure 29. Global Cell Therapy Regenerative Medicine Revenue Market Share by Company in 2022 Figure 30. Global Cell Therapy Regenerative Medicine Sales Market Share by Geographic Region (2018-2023) Figure 31. Global Cell Therapy Regenerative Medicine Revenue Market Share by Geographic Region in 2022 Figure 32. Americas Cell Therapy Regenerative Medicine Sales 2018-2023 (K Units) Figure 33. Americas Cell Therapy Regenerative Medicine Revenue 2018-2023 ($ Millions) Figure 34. APAC Cell Therapy Regenerative Medicine Sales 2018-2023 (K Units) Figure 35. APAC Cell Therapy Regenerative Medicine Revenue 2018-2023 ($ Millions) Figure 36. Europe Cell Therapy Regenerative Medicine Sales 2018-2023 (K Units) Figure 37. Europe Cell Therapy Regenerative Medicine Revenue 2018-2023 ($ Millions) Figure 38. Middle East & Africa Cell Therapy Regenerative Medicine Sales 2018-2023 (K Units) Figure 39. Middle East & Africa Cell Therapy Regenerative Medicine Revenue 2018-2023 ($ Millions) Figure 40. Americas Cell Therapy Regenerative Medicine Sales Market Share by Country in 2022 Figure 41. Americas Cell Therapy Regenerative Medicine Revenue Market Share by Country in 2022 Figure 42. Americas Cell Therapy Regenerative Medicine Sales Market Share by Type (2018-2023) Figure 43. Americas Cell Therapy Regenerative Medicine Sales Market Share by Application (2018-2023) Figure 44. United States Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions) Figure 45. Canada Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions) Figure 46. Mexico Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions) Figure 47. Brazil Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions) Figure 48. APAC Cell Therapy Regenerative Medicine Sales Market Share by Region in 2022 Figure 49. APAC Cell Therapy Regenerative Medicine Revenue Market Share by Regions in 2022 Figure 50. APAC Cell Therapy Regenerative Medicine Sales Market Share by Type (2018-2023) Figure 51. APAC Cell Therapy Regenerative Medicine Sales Market Share by Application (2018-2023) Figure 52. China Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions) Figure 53. Japan Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions) Figure 54. South Korea Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions) Figure 55. Southeast Asia Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions) Figure 56. India Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions) Figure 57. Australia Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions) Figure 58. China Taiwan Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions) Figure 59. Europe Cell Therapy Regenerative Medicine Sales Market Share by Country in 2022 Figure 60. Europe Cell Therapy Regenerative Medicine Revenue Market Share by Country in 2022 Figure 61. Europe Cell Therapy Regenerative Medicine Sales Market Share by Type (2018-2023) Figure 62. Europe Cell Therapy Regenerative Medicine Sales Market Share by Application (2018-2023) Figure 63. Germany Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions) Figure 64. France Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions) Figure 65. UK Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions) Figure 66. Italy Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions) Figure 67. Russia Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions) Figure 68. Middle East & Africa Cell Therapy Regenerative Medicine Sales Market Share by Country in 2022 Figure 69. Middle East & Africa Cell Therapy Regenerative Medicine Revenue Market Share by Country in 2022 Figure 70. Middle East & Africa Cell Therapy Regenerative Medicine Sales Market Share by Type (2018-2023) Figure 71. Middle East & Africa Cell Therapy Regenerative Medicine Sales Market Share by Application (2018-2023) Figure 72. Egypt Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions) Figure 73. South Africa Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions) Figure 74. Israel Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions) Figure 75. Turkey Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions) Figure 76. GCC Country Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions) Figure 77. Manufacturing Cost Structure Analysis of Cell Therapy Regenerative Medicine in 2022 Figure 78. Manufacturing Process Analysis of Cell Therapy Regenerative Medicine Figure 79. Industry Chain Structure of Cell Therapy Regenerative Medicine Figure 80. Channels of Distribution Figure 81. Global Cell Therapy Regenerative Medicine Sales Market Forecast by Region (2024-2029) Figure 82. Global Cell Therapy Regenerative Medicine Revenue Market Share Forecast by Region (2024-2029) Figure 83. Global Cell Therapy Regenerative Medicine Sales Market Share Forecast by Type (2024-2029) Figure 84. Global Cell Therapy Regenerative Medicine Revenue Market Share Forecast by Type (2024-2029) Figure 85. Global Cell Therapy Regenerative Medicine Sales Market Share Forecast by Application (2024-2029) Figure 86. Global Cell Therapy Regenerative Medicine Revenue Market Share Forecast by Application (2024-2029)
